The nation of Zimbabwe has rejected a significant American healthcare agreement worth $367m (£272m) over five years due to the United States' request for sensitive information.
This rejection became public after a official document from December was disclosed, which showed Head of State Emmerson Mnangagwa believed the deal was "skewed".
A government spokesman later explained that the US was requesting biological samples for scientific study and commercial gain while was not willing to share the resulting advantages from any future medical innovations.
"We must now begin the challenging and unfortunate process of ending our health assistance in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont publicly.
Her embassy noted the US had provided over $1.9bn in health funding to Zimbabwe over the last twenty years.
A medical body in Zimbabwe has urged more negotiations to find a deal acceptable to all parties so the country's critical HIV programme can be sustained.
Broader Background
This rejection follows a comparable case in neighbouring Kenya, where a high court blocked a similar health funding agreement following concerns were raised about the safety of citizens' medical information.
After resuming the presidency last year, US President Donald Trump has slashed overseas assistance and shut down the US Agency for International Development (USAID).
USAID had administered aid for the US government, but Trump claimed its spending was "wasteful" and his administration was seeking government-to-government deals to boost transparency and responsibility.
As per statements, 16 nations in Africa have so far agreed to similar agreements, representing over $18.3bn in committed funds.
Specifics of the Rejected Deal
This assistance for Zimbabwe would have funded "HIV/Aids treatment and prevention, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"We believe this cooperation might have yielded immense benefits for Zimbabwean communities, especially the 1.2 million men, women and children presently on antiretroviral therapy through US-supported programmes," the Ambassador said.
However, government spokesperson Nick Mangwana said the proposed deal was "unequal".
"Our nation was requested to share its biological resources and data over an extended period, without any equivalent promise of benefiting from any scientific breakthroughs – like vaccines, diagnostics, or treatments – that might result from that shared data," Mangwana explained.
"In essence, our nation would provide the raw materials for medical research without any assurance that the resulting innovations would be available to our people if a new pandemic emerge."
National Interest and Global Health
He also noted that the American exit from the global health body and its pursuit of one-on-one deals were undermining systems previously set up via the international organization.
Mangwana gave as an example its Pathogen Access and Benefit Sharing scheme designed to deal with future pandemics.
"This framework is designed to guarantee that when a nation provides its data, the resulting advantages – such as medicines and cures – are distributed fairly, not commercialised solely by those with the resources to develop them."
The government's concerns over the US deal "must not be interpreted as hostility towards the US," he added.
"We encourage further dialogue with our US partners on how future co-operation could be structured in a way that respects the sovereignty and interests of each country."
Medical Community Response
The Zimbabwe College of Public Health Physicians (ZCPHP) said it recognised the government's concerns, but urged that talks need to persist given that much of the nation's Aids initiatives depended on international support.
"If technical issues arise, such as those involving information security or implementation frameworks, these can often be resolved through detailed discussion and negotiated safeguards," the group said.
This impasse emphasises the continuing challenges between accepting vital international aid and protecting national sovereignty in an ever more interconnected world.